newsfilter
← Latest News
GlobeNewswire·

Chembio Launches Commercial Distribution of Third-Party COVID-19 Antigen Assay

HAUPPAUGE, N.Y., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced its launch of commercial distribution of an FDA Emergency Use Auth